Strategies and challenges for systematically mapping biologically significant molecular pathways regulating carcinoma epithelial-mesenchymal transition

Cells Tissues Organs

Volumn 197, Issue 6, 2013, Pages 424-434

  Said, Nur Akmarina B M ^a,b   Simpson, Kaylene J ^c,d   Williams, Elizabeth D ^b,d,e  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b MONASH UNIVERSITY   (Australia)

^c PETER MACCALLUM CANCER CENTRE   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Epithelial mesenchymal transition; High content screen; Plasticity

Indexed keywords

ARTICLE; ASSAY; BIOINFORMATICS; CARCINOMA; CELL MIGRATION; CLINICAL TRIAL (TOPIC); DATA ANALYSIS; EPITHELIAL MESENCHYMAL TRANSITION; FUNCTIONAL GENOMICS; GENE EXPRESSION PROFILING; HIGH CONTENT SCREENING; HUMAN; IMAGING; MOLECULAR BIOLOGY; NONHUMAN; ORGANISMS; PHENOTYPE; PRIORITY JOURNAL; SCREENING; TUMOR CELL;

EID: 84878902001     PISSN: 14226405     EISSN: 14226421     Source Type: Journal    
DOI: 10.1159/000351717     Document Type: Article

References (52)

1. Bednarz-Knoll, N., C. Alix-Panabieres, K. Pantel (2012) Plasticity of disseminating cancer cells in patients with epithelial malignancies. Cancer Metastasis Rev 31: 673-687.
2. Bleicher, K.H., H.J. Bohm, K. Muller, A.I. Alanine (2003) Hit and lead generation: beyond highthroughput screening. Nat Rev Drug Discov 2: 369-378.
3. Brabletz, T. (2012) To differentiate or not -routes towards metastasis. Nat Rev Cancer 12: 425-436.
4. Braeutigam, C., L. Rago, A. Rolke, L. Waldmeier, G. Christofori, J. Winter (2013) The RNAbinding protein Rbfox2: an essential regulator of EMT-driven alternative splicing and a mediator of cellular invasion. Oncogene, E-pub ahead of print.
5. Celia-Terrassa, T., O. Meca-Cortes, F. Mateo, A.M. de Paz, N. Rubio, A. Arnal-Estape, B.J. Ell, R. Bermudo, A. Diaz, M. Guerra-Rebollo, J.J. Lozano, C. Estaras, C. Ulloa, D. Alvarez-Simon, J. Mila, R. Vilella, R. Paciucci, M. Martinez- Balbas, A.G. de Herreros, R.R. Gomis, Y. Kang, J. Blanco, P.L. Fernandez, T.M. Thomson (2012) Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells. J Clin Invest 122: 1849-1868.
6. Chaffer, C.L., B. Dopheide, D.R. McCulloch, A.B. Lee, J.M. Moseley, E.W. Thompson, E.D. Williams (2005) Upregulated MT1-MMP/TIMP- 2 axis in the TSU-Pr1-B1/B2 model of metastatic progression in transitional cell carcinoma of the bladder. Clin Exp Metastasis 22: 115-125.
7. Chaffer, C.L., J.P. Brennan, J.L. Slavin, T. Blick, E.W. Thompson, E.D. Williams (2006) Mesenchymal- to-epithelial transition facilitates bladder cancer metastasis: role of fibroblast growth factor receptor-2. Cancer Res 66: 11271-11278.
8. Chua, K.N., W.J. Sim, V. Racine, S.Y. Lee, B.C. Goh, J.P. Thiery (2012) A cell-based small molecule screening method for identifying inhibitors of epithelial-mesenchymal transition in carcinoma. PLoS One 7: e33183.
9. Collins, C.S., J. Hong, L. Sapinoso, Y. Zhou, Z. Liu, K. Micklash, P.G. Schultz, G.M. Hampton (2006) A small interfering RNA screen for modulators of tumor cell motility identifies MAP4K4 as a promigratory kinase. Proc Natl Acad Sci USA 103: 3775-3780.
10. Cram, E.J., H. Shang, J.E. Schwarzbauer (2006) A systematic RNA interference screen reveals a cell migration gene network in C. elegans . J Cell Sci 119: 4811-4818.
11. De Craene, B., G. Berx (2013) Regulatory networks defining EMT during cancer initiation and progression. Nat Rev Cancer 13: 97-110.
12. Gilles, C., M. Polette, J.M. Zahm, J.M. Tournier, L. Volders, J.M. Foidart, P. Birembaut (1999) Vimentin contributes to human mammary epithelial cell migration. J Cell Sci 112: 4615-4625.
13. Gough, A.H., P.A. Johnston (2007) Requirements, features, and performance of high content screening platforms. Methods Mol Biol 356: 41-61.
14. Gumireddy, K., A. Li, P.A. Gimotty, A.J. Klein- Szanto, L.C. Showe, D. Katsaros, G. Coukos, L. Zhang, Q. Huang (2009) KLF17 is a negative regulator of epithelial-mesenchymal transition and metastasis in breast cancer. Nat Cell Biol 11: 1297-1304.
15. Haney, S.A., P. LaPan, J. Pan, J. Zhang (2006) High-content screening moves to the front of the line. Drug Discov Today 11: 889-894.
16. Higashikawa, K., S. Yoneda, M. Taki, H. Shigeishi, S. Ono, K. Tobiume, N. Kamata (2008) Gene expression profiling to identify genes associated with high-invasiveness in human squamous cell carcinoma with epithelial-to-mesenchymal transition. Cancer Lett 264: 256-264.
17. Kiger, A.A., B. Baum, S. Jones, M.R. Jones, A. Coulson, C. Echeverri, N. Perrimon (2003) A functional genomic analysis of cell morphology using RNA interference. J Biol 2: 27.
18. Kim, J.H., A. Cho, H. Yin, D.A. Schafer, G. Mouneimne, K.J. Simpson, K.V. Nguyen, J.S. Brugge, D.J. Montell (2011) Psidin, a conserved protein that regulates protrusion dynamics and cell migration. Genes Dev 25: 730-741.
19. Korn, K., E. Krausz (2007) Cell-based high-content screening of small-molecule libraries. Curr Opin Chem Biol 11: 503-510.
20. Krausz, E. (2007) High-content siRNA screening. Mol Biosyst 3: 232-240.
21. LaGamba, D., A. Nawshad, E.D. Hay (2005) Microarray analysis of gene expression during epithelial-mesenchymal transformation. Dev Dyn 234: 132-142.
22. Lai, S.L., M.R. Miller, K.J. Robinson, C.Q. Doe (2012) The Snail family member Worniu is continuously required in neuroblasts to prevent Elav-induced premature differentiation. Dev Cell 23: 849-857.
23. Lenferink, A.E., C. Cantin, A. Nantel, E. Wang, Y. Durocher, M. Banville, B. Paul-Roc, A. Marcil, M.R. Wilson, M.D. O'Connor-McCourt (2009) Transcriptome profiling of a TGF-β- induced epithelial-to-mesenchymal transition reveals extracellular clusterin as a target for therapeutic antibodies. Oncogene 29: 831-844.
24. Li, Q., C. Chen, A. Kapadia, Q. Zhou, M.K. Harper, J. Schaack, D.V. LaBarbera (2011) 3D models of epithelial-mesenchymal transition in breast cancer metastasis: high-throughput screening assay development, validation, and pilot screen. J Biomol Screen 16: 141-154.
25. Liu, K., K. Hearne, A. Mrsny, C. Staka, R.J. Mrsny (2012) A strategy to improve selectivity and targeting to epithelial-derived cancer cells. J Control Release 164: 205-212.
26. Ma, Q., S. Guin, S.S. Padhye, Y.Q. Zhou, R.W. Zhang, M.H. Wang (2011) Ribosomal protein S6 kinase (RSK)-2 as a central effector molecule in RON receptor tyrosine kinase mediated epithelial to mesenchymal transition induced by macrophage-stimulating protein. Mol Cancer 10: 66.
27. Melani, M., K.J. Simpson, J.S. Brugge, D. Montell (2008) Regulation of cell adhesion and collective cell migration by hindsight and its human homolog RREB1. Curr Biol 18: 532-537.
28. Meliopoulos, V.A., L.E. Andersen, K.F. Birrer, K.J. Simpson, J.W. Lowenthal, A.G. Bean, J. Stambas, C.R. Stewart, S.M. Tompkins, V.W. van Beusechem, I. Fraser, M. Mhlanga, S. Barichievy, Q. Smith, D. Leake, J. Karpilow, A. Buck, G. Jona, R.A. Tripp (2012) Host gene targets for novel influenza therapies elucidated by high-throughput RNA interference screens. FASEB J 26: 1372-1386.
29. Reka, A.K., R. Kuick, H. Kurapati, T.J. Standiford, G.S. Omenn, V.G. Keshamouni (2011) Identifying inhibitors of epithelial-mesenchymal transition by connectivity map-based systems approach. J Thorac Oncol 6: 1784-1792.
30. Said, N.A., E.D. Williams (2009) Remodelling the malignant phenotype: impact of EMT. Drug Discov Today Dis Models 6: 21-25.
31. Shapiro, I.M., A.W. Cheng, N.C. Flytzanis, M. Balsamo, J.S. Condeelis, M.H. Oktay, C.B. Burge, F.B. Gertler (2011) An EMT-driven alternative splicing program occurs in human breast cancer and modulates cellular phenotype. PLoS Genet 7: e1002218.
32. Shiota, M., A. Zardan, A. Takeuchi, M. Kumano, E. Beraldi, S. Naito, A. Zoubeidi, M.E. Gleave (2012) Clusterin mediates TGF-β-induced epithelial-mesenchymal transition and metastasis via Twist1 in prostate cancer cells. Cancer Res 72: 5261-5272.
33. Shirkoohi, R. (2013) Epithelial mesenchymal transition from a natural gestational orchestration to a bizarre cancer disturbance. Cancer Sci 104: 28-35.
34. Simpson, K.J., L.M. Selfors, J. Bui, A. Reynolds, D. Leake, A. Khvorova, J.S. Brugge (2008) Identification of genes that regulate epithelial cell migration using an siRNA screening approach. Nat Cell Biol 10: 1027-1038.
35. Smolen, G.A., J. Zhang, M.J. Zubrowski, E.J. Edelman, B. Luo, M. Yu, L.W. Ng, C.M. Scherber, B.J. Schott, S. Ramaswamy, D. Irimia, D.E. Root, D.A. Haber (2010) A genome-wide RNAi screen identifies multiple RSK-dependent regulators of cell migration. Genes Dev 24: 2654-2665.
36. Snijder, B., L. Pelkmans (2011) Origins of regulated cell-to-cell variability. Nat Rev Mol Cell Biol 12: 119-125.
37. Stoops, S.L., A.S. Pearson, C. Weaver, A.G. Waterson, E. Days, C. Farmer, S. Brady, C.D. Weaver, R.D. Beauchamp, C.W. Lindsley (2011) Identification and optimization of small molecules that restore E-cadherin expression and reduce invasion in colorectal carcinoma cells. ACS Chem Biol 6: 452-465.
38. Taube, J.H., J.I. Herschkowitz, K. Komurov, A.Y. Zhou, S. Gupta, J. Yang, K. Hartwell, T.T. Onder, P.B. Gupta, K.W. Evans, B.G. Hollier, P.T. Ram, E.S. Lander, J.M. Rosen, R.A. Weinberg, S.A. Mani (2010) Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes. Proc Natl Acad Sci USA 107: 15449-15454.
39. Taylor, D.L., K.A. Giuliano (2005) Multiplexed high content screening assays create a systems cell biology approach to drug discovery. Drug Discov Today Technol 2: 149-154.
40. Thiery, J.P. (2002) Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2: 442-454.
41. Thiery, J.P., J.P. Sleeman (2006) Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 7: 131-142.
42. Vetter, G., A. Le Bechec, J. Muller, A. Muller, M. Moes, M. Yatskou, Z. Al Tanoury, O. Poch, L. Vallar, E. Friederich (2009) Time-resolved analysis of transcriptional events during SNAI1-triggered epithelial to mesenchymal transition. Biochem Biophys Res Comm 385: 485-491.
43. Ward, A., A. Balwierz, J.D. Zhang, M. Kublbeck, Y. Pawitan, T. Hielscher, S. Wiemann, O. Sahin (2013) Re-expression of microRNA-375 reverses both tamoxifen resistance and accompanying EMT-like properties in breast cancer. Oncogene 32: 1173-1182.
44. Warzecha, C.C., T.K. Sato, B. Nabet, J.B. Hogenesch, R.P. Carstens (2009a) ESRP1 and ESRP2 are epithelial cell-type-specific regulators of FGFR2 splicing. Mol Cell 33: 591-601.
45. Warzecha, C.C., S. Shen, Y. Xing, R.P. Carstens (2009b) The epithelial splicing factors ESRP1 and ESRP2 positively and negatively regulate diverse types of alternative splicing events. RNA Biol 6: 546-562.
46. Warzecha, C.C., P. Jiang, K. Amirikian, K.A. Dittmar, H. Lu, S. Shen, W. Guo, Y. Xing, R.P. Carstens (2010) An ESRP-regulated splicing programme is abrogated during the epithelial- mesenchymal transition. EMBO J 29: 3286-3300.
47. Warzecha, C.C., R.P. Carstens (2012) Complex changes in alternative pre-mRNA splicing play a central role in the epithelial-to-mesenchymal transition (EMT). Semin Cancer Biol 22: 417-427.
48. Yu, M., A. Bardia, B.S. Wittner, S.L. Stott, M.E. Smas, D.T. Ting, S.J. Isakoff, J.C. Ciciliano, M.N. Wells, A.M. Shah, K.F. Concannon, M.C. Donaldson, L.V. Sequist, E. Brachtel, D. Sgroi, J. Baselga, S. Ramaswamy, M. Toner, D.A. Haber, S. Maheswaran (2013) Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 339: 580-584.
49. Zavadil, J., M. Bitzer, D. Liang, Y.C. Yang, A. Massimi, S. Kneitz, E. Piek, E.P. Bottinger (2001) Genetic programs of epithelial cell plasticity directed by transforming growth factor-β. Proc Natl Acad Sci USA 98: 6686-6691.
50. Zavadil, J., M. Narasimhan, M. Blumenberg, R.J. Schneider (2007) Transforming growth factor-β and microRNA:mRNA regulatory networks in epithelial plasticity. Cells Tissues Organs 185: 157-161.
51. Zhang, K., E. Rodriguez-Aznar, N. Yabuta, R.J. Owen, J.M. Mingot, H. Nojima, M.A. Nieto, G.D. Longmore (2012) Lats2 kinase potentiates Snail1 activity by promoting nuclear retention upon phosphorylation. EMBO J 31: 29-43.
52. Zhao, M., P. Szafranski, C.A. Hall, S. Goode (2008) Basolateral junctions utilize warts signaling to control epithelial-mesenchymal transition and proliferation crucial for migration and invasion of Drosophila ovarian epithelial cells. Genetics 178: 1947-1971.